Best Practices and a Business Case for Surgical Site Infection Prevention

AORN J. 2023 May;117(5):277-290. doi: 10.1002/aorn.13912.

Abstract

Surgical site infections (SSIs) can be costly and result in prolonged hospital stays; readmissions; and additional diagnostic tests, therapeutic antibiotic treatments, and surgical procedures. Evidence-based practices for preventing SSIs include environmental cleaning; instrument cleaning, decontamination, and sterilization; preoperative bathing; preoperative Staphylococcus aureus decolonization; intraoperative antimicrobial prophylaxis; hand hygiene; and surgical hand antisepsis. Strong partnerships among infection prevention personnel, perioperative nurses, surgeons, and anesthesia professionals may enhance perioperative infection prevention. Facility and physician-specific SSI rates should be reported to physicians and frontline personnel in a timely, accessible manner. Together with costs associated with SSIs, these data help determine the success of an infection prevention program. Leaders can develop a comprehensive business case proposal for perioperative infection prevention programs. The proposal should describe the need for the program and anticipated return on investment; it also should focus on the goal of decreasing SSIs by establishing metrics for assessing outcomes and addressing barriers.

Keywords: business case proposal; cost-benefit analysis; health care-associated infection; infection prevention; surgical site infection (SSI).

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antisepsis
  • Humans
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus
  • Surgical Wound Infection* / drug therapy
  • Surgical Wound Infection* / prevention & control

Substances

  • Anti-Bacterial Agents